US EditionCompanies Can Make Generic Ozempic as of Next Week in Canada, but Don’t Expect to Get It Soon
Health Canada has received nine generic semaglutide submissions with an expected 180-day review; generics may cost as low as 35% of brand-name Ozempic, experts say.
- Health Canada has received nine submissions to produce generic versions of semaglutide, the key ingredient in Ozempic and Wegovy diabetes and weight-loss drugs from Novo Nordisk.
- Patients can expect generic semaglutide medications to be priced as low as 35% of the brand-name Ozempic cost, which can be a few hundred dollars a month.
- Generic semaglutide products are complex and manufacturers must show they don't affect the drug's safety, efficacy or quality compared to the brand-name drug.
39 Articles
39 Articles
castanet.net
Companies can make generic Ozempic as of next week, but don't expect to get it soon
Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, but experts say patients shouldn't expect it to be available for at least a few months.
Canadian pharmaceutical companies will be allowed to market cheaper generic versions of Ozempic's successful drug as early as next week, but experts believe that patients should not expect it to be available for sale for several months.
Canada clears generic Ozempic production, but pharmacies won’t stock it immediately
Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, but experts say patients shouldn’t expect it to be available for at least a few months.
TORONTO—Canadian pharmaceutical companies will be allowed to market cheaper generic versions of the successful Ozempic drug next week, but experts believe that patients should not expect to find it for sale before several months. As of December 29, Health Canada had received nine applications for authorization to manufacture semaglutide, the active ingredient of Ozempic and Wegovy, the diabetes and weight loss drug brands manufactured by Novo No…
Canadian pharmaceutical companies will be allowed to market cheaper generic versions of the successful Ozempic drug next week, but experts believe that patients should not expect to find it for sale before several months. By December 29, Health Canada had received nine applications for authorization to manufacture semaglutide, the active ingredient of Ozempic and Wegovy, the diabetes and weight loss drug brands manufactured by Novo Nordisk.
lemanic.ca
Le Nord-CôtierCanadian pharmaceutical companies will be allowed to market cheaper generic versions of the successful Ozempic drug next week, but experts believe that patients should not expect to find it for sale before several months. By December 29, Health Canada had received nine applications for authorization to manufacture semaglutide, the active ingredient of Ozempic and Wegovy, the diabetes and weight loss drug brands manufactured by Novo Nordisk.
Coverage Details
Bias Distribution
- 79% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
